about
Efficacy of allopurinol and benzbromarone for the control of hyperuricaemia. A pathogenic approach to the treatment of primary chronic goutFactors influencing the crystallization of monosodium urate: a systematic literature reviewEvidence for a promoter of urate crystal formation in gouty synovial fluidOverview of Serum Uric Acid Treatment Targets in Gout: Why Less Than 6 mg/dL?Febuxostat in the treatment of gout: 5-yr findings of the FOCUS efficacy and safety study.The role of uric acid as an endogenous danger signal in immunity and inflammation.Wide-field imaging of birefringent synovial fluid crystals using lens-free polarized microscopy for gout diagnosis.Predicting allopurinol response in patients with goutTreating to target: a strategy to cure gout.Use of febuxostat in the management of gout in the United Kingdom.The crystallization of monosodium urate.How neutrophil extracellular traps orchestrate the local immune response in gout.Dual-energy computed tomography has limited diagnostic sensitivity for short-term gout.Growth of monosodium urate monohydrate crystals: effect of cartilage and synovial fluid components on in vitro growth rates.Rapid development of a tophus following ipsilateral hemiparesis.A role of IgM antibodies in monosodium urate crystal formation and associated adjuvanticity.Inflammatory cells in tissues of gout patients and their correlations with comorbidities.Effect of urate-lowering therapy on the velocity of size reduction of tophi in chronic gout.A novel quantitative method for recovering precipitated uric acid in urine and analysis by LC-MS/MS.
P2860
Q24675215-EAE86793-0412-4E8A-80F5-E9709B63F8B0Q26783030-947B0639-8EB4-43F3-822A-8A23C802A829Q33563800-E65CEE12-63BB-4835-A783-E83FC2016887Q34538414-05AC390D-06A7-429B-B434-CAB86904EDBBQ34657910-114DADA5-6157-4BE8-89B3-2839693A2490Q34977644-DB03A8A6-C508-4641-9732-09FD65A2FE53Q36064155-2E9BB394-A96D-485D-B997-09EB0B2C84B6Q36802064-171E13E5-DAF2-4725-8E69-D9F79123629FQ37485337-C692171B-C470-4DE6-B4F1-43BB21F21046Q37649899-25373B5C-D2B9-48BC-93BC-06572923A154Q37683502-C5F1549D-0BB5-453A-A8C4-59C23F65D9F8Q38498741-35E3E9C2-B1E4-4AC8-80A2-8092D1FF4A5CQ39106039-FF232409-FB10-42D7-9306-40DE64655CB0Q41156468-378CA088-B0C7-47E4-8825-1E129383B290Q41288006-FAFB02EA-ADF8-4D40-ADBA-4E9291170020Q42105873-549877E5-CAD9-4DAF-BC85-2306441EB18BQ42152791-C2037646-6FBD-4184-B2C6-4CB7CE42BC0DQ44124046-11684BE9-77A0-402D-8609-32B792F54CA1Q53490676-8D455566-7992-4827-A876-1F476D5F2861
P2860
description
1983 nî lūn-bûn
@nan
1983 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1983 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1983年の論文
@ja
1983年論文
@yue
1983年論文
@zh-hant
1983年論文
@zh-hk
1983年論文
@zh-mo
1983年論文
@zh-tw
1983年论文
@wuu
name
Studies of urate crystallisation in relation to gout.
@ast
Studies of urate crystallisation in relation to gout.
@en
type
label
Studies of urate crystallisation in relation to gout.
@ast
Studies of urate crystallisation in relation to gout.
@en
prefLabel
Studies of urate crystallisation in relation to gout.
@ast
Studies of urate crystallisation in relation to gout.
@en
P2093
P2860
P1476
Studies of urate crystallisation in relation to gout.
@en
P2093
P2860
P356
10.1136/ARD.42.SUPPL_1.12
P407
P478
42 Suppl 1
P577
1983-08-01T00:00:00Z